Compare ACMR & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACMR | MIR |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | United States | United States |
| Employees | N/A | 3281 |
| Industry | Industrial Machinery/Components | Industrial Machinery/Components |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.6B |
| IPO Year | 2017 | N/A |
| Metric | ACMR | MIR |
|---|---|---|
| Price | $97.82 | $17.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $50.00 | $27.25 |
| AVG Volume (30 Days) | 1.8M | ★ 3.9M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $74,643,000.00 | N/A |
| Revenue This Year | $29.37 | $23.95 |
| Revenue Next Year | $23.16 | $7.32 |
| P/E Ratio | $488.79 | ★ $195.00 |
| Revenue Growth | ★ 104.47 | N/A |
| 52 Week Low | $23.03 | $15.58 |
| 52 Week High | $127.19 | $30.28 |
| Indicator | ACMR | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 50.01 | 44.25 |
| Support Level | $35.32 | $16.49 |
| Resistance Level | N/A | $18.97 |
| Average True Range (ATR) | 9.85 | 0.92 |
| MACD | -0.09 | 0.03 |
| Stochastic Oscillator | 14.28 | 30.78 |
ACM Research Inc supplies capital equipment developed for the semiconductor industry. The company focuses on developing differentiated process solutions that enable effective particle removal, uniform material deposition, and reliable process control for the fabricators of integrated circuits. Its product offerings include wet-cleaning, plating, furnace, PECVD, track, and other front-end processing equipment. Additionally, it develops, manufactures, and sells a range of packaging equipment to wafer assembly and packaging customers. Geographically, the company generates maximum revenue from its customers in Mainland China, and the rest from other regions.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.